Post
Algernon announces acceptance of Repirinast patent application in Japan
Algernon Pharmaceuticals’ patent application for NP-251 (Repirinast) has been accepted by the Japanese Patent Office (JPO) for the treatment of …
Negative FDA AdCom vote for Intercept’s obeticholic acid in NASH
On 19 May, the FDA’s Gastrointestinal Drugs Advisory Committee (GDAC), by a vote of 12 to two, with two abstentions, …
UK’s NICE recommends Pfizer’s rimegepant to treat migraine
The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer’s …
USPTO grants Notice of Allowance for Tenax Therapeutics’ oral levosimendan
The US Patent and Trademark Office (USPTO) has granted a Notice of Allowance for Tenax Therapeutics’ patent application covering its …
New UK intracellular drug delivery centre to support RNA development
A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
FDA approves Analog and Dipharma’s ANDA for nitisinone capsules
The US Food and Drug Administration (FDA) has granted clearance to Analog Pharma and Dipharma’s abbreviated new drug application (ANDA) …
(Cilnidipine + tadalafil) by AISA Pharma for Raynauds Disease: Likelihood of Approval
(Cilnidipine + tadalafil) is under clinical development by AISA Pharma and currently in Phase II for Raynauds Disease. According to …
RO-7446603 by Genentech USA for Diabetic Macular Edema: Likelihood of Approval
RO-7446603 is under clinical development by Genentech USA and currently in Phase I for Diabetic Macular Edema. According to GlobalData, …
TQB-3454 by Chia Tai Tianqing Pharmaceutical Group for Solid Tumor: Likelihood of Approval
TQB-3454 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase I for Solid Tumor. According …
Decoy-20 by Indaptus Therapeutics for Colorectal Cancer: Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase …
Sintilimab by Innovent Biologics for Metastatic Melanoma: Likelihood of Approval
Sintilimab is under clinical development by Innovent Biologics and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase …
MB-272 by Gilead Sciences for Autoimmune Disorders: Likelihood of Approval
MB-272 is under clinical development by Gilead Sciences and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase …
Landiolol hydrochloride by AOP Health for Supraventricular Tachycardia: Likelihood of Approval
Landiolol hydrochloride is under clinical development by AOP Health and currently in Pre-Registration for Supraventricular Tachycardia. According to GlobalData, Pre-Registration …
Nadofaragene firadenovec by Ferring International Center for Malignant Pleural Mesothelioma: Likelihood of Approval
Nadofaragene firadenovec is under clinical development by Ferring International Center and currently in Phase III for Malignant Pleural Mesothelioma. According …
GRANITE-001 by Gritstone Bio for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
GRANITE-001 is under clinical development by Gritstone Bio and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction. According …